[HTML][HTML] Mechanisms of acquired resistance and tolerance to EGFR targeted therapy in non-small cell lung cancer
H Chhouri, D Alexandre, L Grumolato - Cancers, 2023 - mdpi.com
Simple Summary Lung cancer is the major cause of cancer-related deaths worldwide. The
development of targeted therapies has dramatically improved the outcome of lung cancer …
development of targeted therapies has dramatically improved the outcome of lung cancer …
Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer
H Chhouri, D Alexandre, L Grumolato - Cancers, 2023 - pubmed.ncbi.nlm.nih.gov
Non-small cell lung cancers (NSCLC) harboring activating mutations of the epidermal
growth factor receptor (EGFR) are treated with specific tyrosine kinase inhibitors (EGFR …
growth factor receptor (EGFR) are treated with specific tyrosine kinase inhibitors (EGFR …
[HTML][HTML] Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer
H Chhouri, D Alexandre, L Grumolato - Cancers, 2023 - ncbi.nlm.nih.gov
Non-small cell lung cancers (NSCLC) harboring activating mutations of the epidermal
growth factor receptor (EGFR) are treated with specific tyrosine kinase inhibitors (EGFR …
growth factor receptor (EGFR) are treated with specific tyrosine kinase inhibitors (EGFR …
Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer.
H Chhouri, D Alexandre, L Grumolato - Cancers, 2023 - search.ebscohost.com
Abstract Simple Summary: Lung cancer is the major cause of cancer-related deaths
worldwide. The development of targeted therapies has dramatically improved the outcome …
worldwide. The development of targeted therapies has dramatically improved the outcome …
Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer.
H Chhouri, D Alexandre, L Grumolato - Cancers, 2023 - europepmc.org
Non-small cell lung cancers (NSCLC) harboring activating mutations of the epidermal
growth factor receptor (EGFR) are treated with specific tyrosine kinase inhibitors (EGFR …
growth factor receptor (EGFR) are treated with specific tyrosine kinase inhibitors (EGFR …
[PDF][PDF] Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer
H Chhouri, D Alexandre, L Grumolato - Nat. Rev. Cancer, 2017 - researchgate.net
Non-small cell lung cancers (NSCLC) harboring activating mutations of the epidermal
growth factor receptor (EGFR) are treated with specific tyrosine kinase inhibitors (EGFR …
growth factor receptor (EGFR) are treated with specific tyrosine kinase inhibitors (EGFR …
Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer
H Chhouri, D Alexandre, L Grumolato - Cancers, 2023 - search.proquest.com
Non-small cell lung cancers (NSCLC) harboring activating mutations of the epidermal
growth factor receptor (EGFR) are treated with specific tyrosine kinase inhibitors (EGFR …
growth factor receptor (EGFR) are treated with specific tyrosine kinase inhibitors (EGFR …